$33.00
-7.96-19.43%
Last update: 2:20 PM
15 minutes delayed
Celldex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Celldex Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.54 | $-0.60 | 10.0 % |
Mar 2024 | 2024-05-06 | $-0.56 | $-0.69 | 18.8 % |
Dec 2023 | 2024-02-26 | $-0.83 | $-0.74 | -12.2 % |
Sep 2023 | 2023-11-02 | $-0.81 | $-0.68 | -19.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $2.50M | $820.43K | 204.5 % |
Mar 2024 | 2024-05-06 | $156.00K | $920.00K | -83.0 % |
Dec 2023 | 2024-02-26 | $4.13M | $840.00K | 391.9 % |
Sep 2023 | 2023-11-02 | $1.52M | $580.00K | 161.5 % |
Celldex Therapeutics (CLDX) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.54, which beat the estimate of $-0.60.
The Actual Revenue was $2.5M, which beat the estimate of $820.4K.
Browse earnings estimates, EPS, and revenue on all stocks.